Претраживање
Приказ резултата 11-13 од 13
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Plasma fatty acid composition in overweight patients with hypertriglyceridemia
(Elsevier Ireland Ltd, Clare, 2006)
Erythrocyte fatty acid composition in obese patients with hyperlipidemia
(Elsevier Ireland Ltd, Clare, 2006)